Skip to main content

Weil-McLain Ordered To Pay $8.45 Million in an Asbestos Case

Weil-McLain Ordered To Pay $8.45 Million in an Asbestos Case

Weil-McLain Ordered To Pay $8.45 Million in an Asbestos Case

Introduction

In a recent verdict, a Los Angeles County jury announced $ 8.45 million to be awarded to a victim's son over the lawsuit allegations that the victim developed mesothelioma due to the asbestos exposure while working at Weil-McLain. The jury found the boiler manufacturer 60% liable for causing him deadly cancer, making them responsible for $5.070 million of the total award for being grossly negligent.

The victim worked as a career plumber and pipefitter for Weil-McLain brand boilers, where his job mainly involved asbestos insulation on the boilers. And during maintenance, he used to scrape and clean off old asbestos gaskets before installing new ones. He testified that asbestos exposure during installation caused him lung cancer, which was diagnosed in October 2014. His medical records reveal, he underwent extrapleural pneumonectomy to remove the cancerous lung followed by chemotherapy and radiation. His vocal cords got destroyed during the procedure, and 16 months later he succumbed to death,

The asbestos trial presided over by Hon. C. Edward Simpson against the manufacturer started on July 23. This is believed to be the largest verdict against Weil-McLain to date.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!